Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.30 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | GALR3 | O60755 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24147202 | 0.86 | — | — | |
| SCHEMBL24147217 | 0.81 | CTSK (0.31) | — | |
| SCHEMBL24147201 | 0.74 | TSHR (0.33) | TSHRTDP1SMN1; SMN2MAPTKDM4E | |
| SCHEMBL24147213 | 0.74 | — | — | |
| SCHEMBL24108204 | 0.70 | TSHR (0.37) | TSHRTDP1SMN1; SMN2MAPTMAPK1 | |
| SCHEMBL24147287 | 0.70 | CTSK (0.33) | TSHRTDP1 | |
| SCHEMBL24146455 | 0.70 | MEN1 (0.33) | TSHRMAPTKDM4EMEN1KMT2A | |
| SCHEMBL9735359 | 0.69 | MAPK1 (0.34) | TSHRTDP1SMN1; SMN2MAPTKDM4E | |
| SCHEMBL24147200 | 0.69 | KDM4E (0.33) | TSHRMAPTKDM4EMEN1KMT2A | |
| SCHEMBL24108407 | 0.69 | CYP11B1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230247901-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | NOVALED GMBH (DE) | 2023-08-03 | — | — | US | disclosed |
| WO-2023275021-A1 | ORGANIC COMPOUND OF FORMULA (I) FOR USE IN ORGANIC ELECTRONIC DEVICES, AN ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (I) AND A DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE | NOVALED GMBH (DE) | 2023-01-05 | — | — | WO | disclosed |
| EP-4113639-A1 | ORGANIC COMPOUND OF FORMULA (I) FOR USE IN ORGANIC ELECTRONIC DEVICES, AN ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (I) AND A DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE | Novaled GmbH (DE) | 2023-01-04 | — | — | EP | disclosed |
| WO-2022263531-A1 | ACTIVE-MATRIX OLED DISPLAY | NOVALED GMBH (DE) | 2022-12-22 | — | — | WO | disclosed |
| EP-4106027-A1 | ACTIVE-MATRIX OLED DISPLAY | Novaled GmbH (DE) | 2022-12-21 | — | — | EP | disclosed |
| EP-3989305-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (1), DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE AS WELL AS COMPOUNDS OF FORMULA (1) FOR USE IN ORGANIC ELECTRONIC DEVICES | Novaled GmbH (DE) | 2022-04-27 | — | — | EP | disclosed |
| WO-2021259784-A2 | ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (I), DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE AS WELL AS COMPOUNDS OF FORMULA (I) FOR USE IN ORGANIC ELECTRONIC DEVICES | NOVALED GMBH (DE) | 2021-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230247901-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | AOX1, CYP2C19, CYP2C9 | TSHR 4329/4885TDP1 2861/4885SMN1; SMN2 3520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.